Literature DB >> 25953077

Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.

Kanterpersad Ramcharan1, Kamille Abdool2, Navindra Persad2, Haramnauth Dyaanand3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25953077      PMCID： PMC4434388          DOI： 10.1136/bcr-2014-209201

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.

Authors:  G K Bertsias; J P A Ioannidis; M Aringer; E Bollen; S Bombardieri; I N Bruce; R Cervera; M Dalakas; A Doria; J G Hanly; T W J Huizinga; D Isenberg; C Kallenberg; J C Piette; M Schneider; N Scolding; J Smolen; A Stara; I Tassiulas; M Tektonidou; A Tincani; M A van Buchem; R van Vollenhoven; M Ward; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

Review 2.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

Review 3.  Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.

Authors:  M Carecchio; R Cantello; C Comi
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.